Previous 10 | Next 10 |
In this article, I will be covering a couple of lessons I learned from the Qualcomm ( QCOM )/NXP Semiconductor ( NXPI ) deal that can be applied to the latest mega-merger that is facing questions: Bristol-Myers Squibb ( BMY ) and Celgene ( CELG ). Lesson #1: Watch the spread From the begin...
Important (bad) news came out yesterday with Celgene ( CELG ) down ~7% after-hours because of large Bristol-Myers ( BMY ) shareholder Wellington coming in and opposing the deal. I already flagged Wellington as the most important/likely shareholder to oppose the deal. Here's their rationale ...
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval for Teva Pharmaceutical Industries' (NYSE: TEVA ) Pazenir (paclitaxel), a generic version of Celgene's (NASDAQ: CELG ) Abraxane. More news on: Teva Pharmaceutical Industries Limited, ...
By Breakingviews Bristol-Myers Squibb's (BMY) acquisition of Celgene (CELG) needs surgery. Two of the U.S. pharmaceutical group's shareholders - Wellington Management and activist Starboard Value - have come out against the $74-billion deal it struck with the biotech firm in January. The m...
Is Bristol-Myers Squibb ([[BMY]]) going to buy Celgene ([[CELG]]) or not? Most such deals go through, but the exceptions are big ones (such as Pfizer's ([[PFE]]) bid for AstraZeneca ([[AZN]])). The uncertainty has come in because of yesterday's announcement from Wellington Management Company...
Novavax (NASDAQ: NVAX ) -64% after RSV vaccine flunks late-stage study. More news on: Novavax, Inc., Syneos Health, Inc., Box, Stocks on the move, Read more ...
Today's Top Stories: Latest GDP reading in focus; South Korean futures and currency down after nuke talks collapse; and Starbucks rival Luckin Coffee setting up for U.S. IPO. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following pl...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Wall Street is pointing to modest declines, with U.S. stock index futures down 0.3% , amid shaky trade...
U.S. FDA grants Priority Review for REVLIMID ® (lenalidomide) in combination with rituximab (R²) for previously treated follicular and marginal zone lymphoma Prescription Drug User Fee Act action date set for June 27, 2019 Luspatercept Biologics License Application ...
Agios Pharmaceuticals ( AGIO +5% ) is up on light volume in early trade in response to updated data from a Phase 1 clinical trial evaluating TIBSOVO (ivosidenib), combined with Celgene's ( CELG +0.8% ) VIDAZA (azacitidine), for the first-line treatment of patients with IDH1 mutation-po...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...